- Home
- PDI vs ICLR Comparison
PDI vs ICLR Comparison
Compare PDI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDI | ICLR |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 7.1B |
| IPO Year | 2012 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PDI | ICLR |
|---|---|---|
| Price | $17.61 | $98.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $182.08 |
| AVG Volume (30 Days) | 2.7M | ★ 3.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.00 | $66.57 |
| 52 Week High | $20.05 | $211.00 |
Technical Indicators
Market Signals| Indicator | PDI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 30.33 | 32.36 |
| Support Level | $17.60 | $66.57 |
| Resistance Level | $17.82 | $113.88 |
| Average True Range (ATR) | 0.19 | 4.91 |
| MACD | -0.06 | 2.42 |
| Stochastic Oscillator | 17.72 | 1.12 |
Price Performance
Historical ComparisonAbout PDI PIMCO Dynamic Income Fund
PIMCO Dynamic Income Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek current income. Its secondary objective is to seek capital appreciation. The fund invests world-wide in a portfolio of debt obligations and other income-producing securities with varying maturities and related derivative instruments. Its investment portfolio includes mortgage-backed securities, investment-grade, and high-yield corporates, corporate and sovereign bonds, other income-producing securities, and related derivative instruments.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.